![](https://investorshub.advfn.com/uicon/440329.png?cb=1484301727)
Thursday, September 02, 2021 3:05:09 AM
Arguments about CDMO is a red herring. I don’t recall ever being told during any of the funding rounds that my money was to be used to set up a third party CDMO…..I was told it’s being used to build up Sawston vital for the commercial success of DCVax. I was told we are going it alone and will become the leading biotech in the field of cancer. That’s why NWBO purchased Sawston in the first place…..
When the licence is awarded to make DCVax at Sawston on a commercial level do you believe that it will be in the name of Northwest Biotherapeutics or in the name of Advent Bioservices? It’s an important question because if it’s the later that means we will have no choice but to purchase the vaccine from them and it begs the question why did we pour so much money into buying the site, selling it for a profit to then kit it out without ever intending to benefit from the ability to operate it……running a CDMO is highly lucrative (cognate sold for a very good premium) and equally the ability to deliver commercial scale production of DCVax within Northwest Biotherapeutics is also valuable.
It could be that the transfer price between Advent and NWBO will be very low and that would be welcomed but it could also be just a few points off what an independent Cognate will charge and we know that is extremely lucrative…..we will never know that transfer price due to commercial confidentiality.
As for the fact we are protected by the auditors report….honestly tell that to the long list of shareholders caught up in scandals. It’s a joke and offers virtually no incentive to dig deeper than the light touch approach based on the auditor relying on the integrity of what they are told. That’s how the system works everywhere.
Everyone has a position and just as it’s obviously biased when you get opinions consistently attacking the science and Mgt. Equally you get others that go on the offensive when anyone raises any red flags about anything to do with corporate governance or the science. They act like employees defending the company when they are not……they are shareholders just like pretty much everyone that posts in here. All of these important questions raised are perfectly okay to ask and could simply be answered with clarity and transparency at any time by Mgt which ultimately is in the best interests of everyone involved, including them. Having been attacked relentlessly in the past I’ve no doubt they are very much aware of this fact and I’m relying on that to believe they will provide complete transparency on this matter.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
FEATURED ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM